Amgen price target cut to $425 by HSBC
HSBC cut its Amgen rating to Hold from Buy and lowered its price target to $425.00 from $445.00, according to Benzinga via TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.